EuroPCR 2026

21 May 2026

Other coronary interventions

Active unloading with Impella heart pumps in elective and emergent patients

Sponsored by Johnson & Johnson MedTech | Heart Recovery

Anchorperson: T. Rudolph

Discussants: G. Tarantini, A. Ughetto, N. Mangner

SHOW MORE

Summary

This session presents the latest evidence on the use of microaxial Impella heart pumps in both elective high-risk and emergent cardiogenic shock patients. It highlights the importance of organised systems of care in improving survival outcomes and explores current data and expert consensus on mechanical circulatory support applications and high-risk PCI in patients unsuitable for surgery. The session challenges traditional paradigms by comparing 'door to unload' versus 'door to balloon' strategies, emphasising evidence-based management approaches.

Learning Objectives

To review the latest evidence on microaxial/Impella pumps in cardiogenic shock and in elective high-risk patients
To understand how organised systems of care can improve survival in cardiogenic shock
To appraise current data and consensus on mechanical circulatory support and high-risk PCI in patients unsuitable for surgery

Speaker

Microaxillary flow pump in elective patients - When do the benefits outweigh the risks?

Download presentation